ACS Includes Cologuard in Prevention and Early Detection Guidelines
Updated ACS guidelines for colorectal cancer include recommended use of a noninvasive stool-based DNA screening test every 3 years.
Read More
Search Results for: prostate cancer
Study: ISET Detects CTCs for Early Diagnosis of Lung Cancer
In a recent study, the ISET test by Rarecells detected lung cancer in patients with no symptoms, allowing for surgical removal prior to metastasis.
Read MoreResearchers Discover Gene That Can Predict Aggressive Prostate Cancer at Diagnosis
An MD Anderson study identifies a genetic variant near the KLK3 gene that could stratify GS7 prostate cancer patients.
Read More
Myriad Publishes myRisk Hereditary Cancer Study
A new study in the journal Cancer finds that Myriad’s myRisk hereditary cancer test identifies 43% more patients with breast cancer risk.
Read MoreBlood Test for “Nicked” Protein Predicts Prostate Cancer Treatment Response
A preliminary study suggests that metastatic prostate cancer patients with detectable levels of AR-V7 in their blood should avoid two widely used drugs.
Read More